# Wellington Management's Biotech Investments: 62 Startups in Its Portfolio (2026) > The 62 Biotech startups Wellington Management has backed, by stage: $16B raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/wellington-management-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Series C and later 27 - [Blueprint Medicines](https://millionrounds.com/company/blueprint-medicines) - [Kymera Therapeutics](https://millionrounds.com/company/kymera-therapeutics) - [Avidity Biosciences](https://millionrounds.com/company/avidity-biosciences) - [Moderna](https://millionrounds.com/company/moderna) - [Arcus Biosciences](https://millionrounds.com/company/arcus-biosciences) - [Tubulis](https://millionrounds.com/company/tubulis) - [Galecto](https://millionrounds.com/company/galecto) - [*A* Atreca](https://millionrounds.com/company/atreca) - [*ZL* Zai Lab](https://millionrounds.com/company/zai-lab) - [Beta Bionics](https://millionrounds.com/company/beta-bionics) - [Obsidian Therapeutics](https://millionrounds.com/company/obsidian-therapeutics) - [Bluejay Therapeutics](https://millionrounds.com/company/bluejay-therapeutics) - [RayzeBio](https://millionrounds.com/company/rayzebio) - [Atsena Therapeutics](https://millionrounds.com/company/atsena-therapeutics) - [Scorpion Therapeutics](https://millionrounds.com/company/scorpion-therapeutics) - [Mersana Therapeutics](https://millionrounds.com/company/mersana-therapeutics) - [Boundless Bio](https://millionrounds.com/company/boundless-bio) - [PMV Pharmaceuticals](https://millionrounds.com/company/pmv-pharmaceuticals) - [FORMA Therapeutics](https://millionrounds.com/company/forma-therapeutics) - [Civitas Therapeutics](https://millionrounds.com/company/civitas-therapeutics) - [*ST* SiteOne Therapeutics](https://millionrounds.com/company/siteone-therapeutics) - [FORE Biotherapeutics](https://millionrounds.com/company/fore-biotherapeutics) - [*N* NightstaRx](https://millionrounds.com/company/nightstarx) - [Strata Oncology](https://millionrounds.com/company/strata-oncology) +3 more ## Series B 14 - [Artiva Biotherapeutics](https://millionrounds.com/company/artiva-biotherapeutics) - [Global Blood Therapeutics](https://millionrounds.com/company/global-blood-therapeutics) - [Voyager Therapeutics](https://millionrounds.com/company/voyager-therapeutics) - [Upstream Bio](https://millionrounds.com/company/upstream-bio) - [Gracell Biotechnologies](https://millionrounds.com/company/gracell-biotechnologies) - [Generation Bio](https://millionrounds.com/company/generation-bio) - [Neon Therapeutics](https://millionrounds.com/company/neon-therapeutics) - [Black Diamond Therapeutics](https://millionrounds.com/company/black-diamond-therapeutics) - [Alkeus Pharmaceuticals](https://millionrounds.com/company/alkeus-pharmaceuticals) - [Freeline](https://millionrounds.com/company/freeline) - [Chroma Medicine](https://millionrounds.com/company/chroma-medicine) - [*FS* Forty Seven](https://millionrounds.com/company/forty-seven) - [Allena Pharmaceuticals](https://millionrounds.com/company/allena-pharmaceuticals) - [Nivalis Therapeutics](https://millionrounds.com/company/nivalis-therapeutics) ## Stage not reported 13 - [Apogee Therapeutics](https://millionrounds.com/company/apogee-therapeutics) - [Nuvalent](https://millionrounds.com/company/nuvalent) - [Centessa Pharmaceuticals](https://millionrounds.com/company/centessa-pharmaceuticals) - [Nurix Therapeutics](https://millionrounds.com/company/nurix-therapeutics) - [Vets First Choice](https://millionrounds.com/company/vets-first-choice) - [Cogent Biosciences](https://millionrounds.com/company/cogent-biosciences) - [Crescent Biopharma](https://millionrounds.com/company/crescent-biopharma) - [Acrivon Therapeutics](https://millionrounds.com/company/acrivon-therapeutics) - [CARGO Therapeutics](https://millionrounds.com/company/cargo-therapeutics) - [Aligos Therapeutics](https://millionrounds.com/company/aligos-therapeutics) - [Entrada Therapeutics](https://millionrounds.com/company/entrada-therapeutics) - [*SP* Sasuma Pharmaceuticals](https://millionrounds.com/company/sasuma-pharmaceuticals) - [Scribe Therapeutics](https://millionrounds.com/company/scribe-therapeutics) ## Series A 8 - [Dyne Therapeutics](https://millionrounds.com/company/dyne-therapeutics) - [Nuvation Bio](https://millionrounds.com/company/nuvation-bio) - [Rhythm Pharmaceuticals](https://millionrounds.com/company/rhythm-pharmaceuticals) - [Disc Medicine](https://millionrounds.com/company/disc-medicine) - [Verve Therapeutics](https://millionrounds.com/company/verve-therapeutics) - [*GT* Gemini Therapeutics](https://millionrounds.com/company/gemini-therapeutics) - [Satsuma Pharmaceuticals](https://millionrounds.com/company/satsuma-pharmaceuticals) - [Carisma](https://millionrounds.com/company/carisma) ## Segment by segment ### Series C and later 27 startups · $7.9B raised - [**Blueprint Medicines**](https://millionrounds.com/company/blueprint-medicines) Blueprint Medicines is a global, fully integrated biopharmaceutical company that invents life-changing medicines. United States $1.4B - [**Kymera Therapeutics**](https://millionrounds.com/company/kymera-therapeutics) Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation. United States $799M - [**Avidity Biosciences**](https://millionrounds.com/company/avidity-biosciences) Synapse Energy Economics is a consulting firm providing economic and policy analysis for the electric power sector. United States $790M - [**Moderna**](https://millionrounds.com/company/moderna) Learn how we’re changing the world of medicine. United States $675M - [**Arcus Biosciences**](https://millionrounds.com/company/arcus-biosciences) Arcus Biosciences is a biopharmaceutical company that discovers, develops, and commercializes novel therapies for the treatment of cancer. United States $427M - [**Tubulis**](https://millionrounds.com/company/tubulis) Tubulis is a chemotherapeutic medication developer specializing in cancer and chronic disease treatment. Germany $401M - [**Galecto**](https://millionrounds.com/company/galecto) Galecto is a clinical stage biotechnology company focused on the development of novel treatments for fibrosis and cancer. Denmark $365M - [*A* **Atreca**](https://millionrounds.com/company/atreca) Atreca develops a technology to identify the set of antibodies produced during an immune response, without prior knowledge of an antigen. United States $313M ### Series B 14 startups · $2.5B raised - [**Artiva Biotherapeutics**](https://millionrounds.com/company/artiva-biotherapeutics) Artiva Biotherapeutics is a biotech company focused on developing and commercializing allogeneic natural killer (NK) cell therapies. United States $420M - [**Global Blood Therapeutics**](https://millionrounds.com/company/global-blood-therapeutics) GBT is a clinical-stage biopharmaceutical company developing a therapy for sickle cell disease. United States $389M - [**Voyager Therapeutics**](https://millionrounds.com/company/voyager-therapeutics) Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology. United States $205M - [**Upstream Bio**](https://millionrounds.com/company/upstream-bio) Upstream Bio focuses on developing an antibody therapy for the treatment of severe asthma. United States $200M - [**Gracell Biotechnologies**](https://millionrounds.com/company/gracell-biotechnologies) Gracell Biotechnologies is a developer of cancer immune therapy designed to treat cancer. China $185M - [**Generation Bio**](https://millionrounds.com/company/generation-bio) Generation Bio is a biotechnology company that develops genetic medicines to treat genetic disorders. United States $176M - [**Neon Therapeutics**](https://millionrounds.com/company/neon-therapeutics) NEON Therapeutics is focused on unlocking the full potential of the immune system to recognize and attack cancer. United States $161M - [**Black Diamond Therapeutics**](https://millionrounds.com/company/black-diamond-therapeutics) Black Diamond Therapeutics is a medical company focused on analyzing genetically defined cancers. United States $160M ### Stage not reported 13 startups · $3.5B raised - [**Apogee Therapeutics**](https://millionrounds.com/company/apogee-therapeutics) Apogee Therapeutics is a biotechnology company that offers therapies for immunological and inflammatory disorders. United States $1.3B - [**Nuvalent**](https://millionrounds.com/company/nuvalent) Nuvalent is a biopharmaceutical company that develops targeted therapies for cancer by designing small-molecule medicines. United States $500M - [**Centessa Pharmaceuticals**](https://millionrounds.com/company/centessa-pharmaceuticals) Centessa Pharmaceuticals is a pharmaceutical company that focuses on drug development to address significant medical needs. United States $250M - [**Nurix Therapeutics**](https://millionrounds.com/company/nurix-therapeutics) Nurix Therapeutics is a biopharmaceutical company that focuses on the development and discovery of small molecule drugs. United States $250M - [**Vets First Choice**](https://millionrounds.com/company/vets-first-choice) Vets First Choice provides veterinary practices with an online pharmacy and home delivery services. United States $227M - [**Cogent Biosciences**](https://millionrounds.com/company/cogent-biosciences) Cogent Biosciences is a biotechnology company that develops therapies for solid cancer tumors. United States $200M - [**Crescent Biopharma**](https://millionrounds.com/company/crescent-biopharma) Crescent Biopharma is a biotechnology firm focused on developing novel precision-engineered medicines. United States $185M - [**Acrivon Therapeutics**](https://millionrounds.com/company/acrivon-therapeutics) Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success. United States $130M ### Series A 8 startups · $2.6B raised - [**Dyne Therapeutics**](https://millionrounds.com/company/dyne-therapeutics) Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases. United States $828M - [**Nuvation Bio**](https://millionrounds.com/company/nuvation-bio) Nuvation Bio is a global biopharmaceutical company focusing on unmet needs in oncology. United States $675M - [**Rhythm Pharmaceuticals**](https://millionrounds.com/company/rhythm-pharmaceuticals) Rhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeutics United States $311M - [**Disc Medicine**](https://millionrounds.com/company/disc-medicine) Disc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood disorders. United States $275M - [**Verve Therapeutics**](https://millionrounds.com/company/verve-therapeutics) Verve Therapeutics is a genetic medicine firm that is developing treatments for cardiovascular disease. United States $202M - [*GT* **Gemini Therapeutics**](https://millionrounds.com/company/gemini-therapeutics) Gemini Therapeutics focuses on genetically-defined dry age-related macular degeneration (AMD) and associated rare genetic diseases. United States $138M - [**Satsuma Pharmaceuticals**](https://millionrounds.com/company/satsuma-pharmaceuticals) Satsuma Pharmaceuticals is a clinical-stage biopharmaceutical company engaged in developing a novel therapeutic product. United States $92M - [**Carisma**](https://millionrounds.com/company/carisma) Carisma is a provider of outsourced managed IT services. United States $53M **How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names Wellington Management as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Sector portfolio **Wellington Management's AI portfolio** 26 startups · $67B](https://millionrounds.com/portfolio-maps/wellington-management-ai-portfolio)[Sector portfolio **Wellington Management's Fintech portfolio** 22 startups · $15B](https://millionrounds.com/portfolio-maps/wellington-management-fintech-portfolio)[Sector portfolio **Wellington Management's Healthtech portfolio** 12 startups · $3.2B](https://millionrounds.com/portfolio-maps/wellington-management-healthtech-portfolio)[Sector portfolio **Wellington Management's Pharma portfolio** 11 startups · $2.2B](https://millionrounds.com/portfolio-maps/wellington-management-pharma-portfolio)[Co-investors **Who invests with Wellington Management** 257 co-investors](https://millionrounds.com/portfolio-maps/wellington-management-co-investors)[Portfolio map **Wellington Management portfolio map** 170 startups · $127B](https://millionrounds.com/portfolio-maps/wellington-management-portfolio-map) ## Raising from investors like Wellington Management? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)